Clinical Trial Update: A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving patients previously enrolled in Roche-sponsored atezolizumab studies; currently active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING